Amit Srivastava, MD
Interventional Cardiology · Edgewood, KYNPI 1932209608
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Terumo Medical Corporation at 39.9% of the total. Among interventional cardiology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,129 payments — averaging $568.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$256K
- Penumbra, Inc.$83K
- Shockwave Medical, Inc$76K
- Cardiovascular Systems Inc.$75K
- Angiodynamics, Inc.$56K
- Abbott$39K
- plus $55K from 30 others
Across 15 payments — averaging $6257.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Terumo Medical Corporation$85K
- Cardiovascular Systems Inc.$7K
- Surmodics, Inc.$2K
What the payments were for
- Consulting fees$300,22447%
- Speaking & faculty fees$226,75535%
- Travel & lodging$59,8079%
- Food & beverage$46,1327%
- Other$9,1671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 233 | $256,425 |
| Penumbra, Inc. | 141 | $83,442 |
| Shockwave Medical, Inc | 158 | $76,062 |
| Cardiovascular Systems Inc. | 239 | $75,462 |
| Angiodynamics, Inc. | 56 | $56,224 |
| Abbott | 79 | $39,101 |
| W. L. Gore & Associates, Inc. | 49 | $21,722 |
| Cordis US CORP. | 14 | $13,499 |
| Surmodics, Inc. | 12 | $11,535 |
| Medtronic(2 entities) | 61 | $3,104 |
| Inari Medical, Inc. | 10 | $1,199 |
| Philips North America LLC | 19 | $1,077 |
| Abiomed | 7 | $496 |
| Intact Vascular, Inc. | 4 | $472 |
| Reflow Medical Inc | 8 | $305 |
| Acist Medical Systems, Inc. | 9 | $276 |
| Celonova Biosciences, Inc. | 1 | $266 |
| Osprey Medical Inc | 3 | $204 |
| Stryker | 1 | $153 |
| Boston Scientific | 4 | $137 |
| Asahi Intecc USA, Inc. | 1 | $131 |
| Okami Medical, Inc. | 1 | $128 |
| Avantec Vascular Corporation | 1 | $127 |
| Edwards Lifesciences | 1 | $108 |
| Bard Peripheral Vascular, Inc. | 1 | $105 |
| Bolton Medical Inc | 1 | $60 |
| E.r. Squibb & Sons, L.L.C. | 1 | $44 |
| Amgen | 2 | $37 |
| EKOS Corporation | 2 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $34 |
| AstraZeneca | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Novartis | 1 | $18 |
| Nuwellis, Inc. | 1 | $17 |
| Cagent Vascular Inc | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GlideWire$125,971
- GLIDESHEATH SLENDER$94,458
- Navicross$85,757
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$73,585
- Glidesheath$67,409
- TR Band$61,148
- Indigo System$59,445
- Auryon Laser System 100-120 Vac$48,147
- R2P MISAGO$44,402
- METACROSS OTW$44,280
- Peripheral Orbital Atherectomy System$35,266
- Diamondback Peripheral$25,079
- Indigo$21,222
- Coronary Orbital Atherectomy System$19,211
- Optitorque$15,825
- Heartrail$15,825
- Sublime 014 Rx PTA Balloon Dilatation Catheter$11,235
- Sublime Microcatheter, 018, 200cm, Straight$11,235
- ANGIO-SEAL$10,250
- AZUR$8,133
How this compares
$642,084 in reported general payments places this provider in the 95th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 187 | $237,848 |
| XareltoRivaroxaban | 55 | $59,957 |
| Repatha SureclickEvolocumab | 18 | $28,365 |
| ClopidogrelClopidogrel Bisulfate | 1,096 | $12,411 |
| Repatha SyringeEvolocumab | 13 | $6,898 |
| Metoprolol Succinate | 452 | $5,810 |
| Prasugrel Hcl | 19 | $2,569 |
| Atorvastatin Calcium | 286 | $2,318 |
| Nitroglycerin | 60 | $1,631 |
| Valsartan | 37 | $1,474 |
| Potassium Chloride | 68 | $1,458 |
| Ranolazine ErRanolazine | 16 | $1,306 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 90 | $1,293 |
| Amlodipine Besylate | 223 | $1,170 |
| Ezetimibe | 37 | $938 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $237,848187 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 129 interventional cardiology providers in Kentucky.
Other interventional cardiology in Edgewood
- Mohanjit BrarEdgewood$76K
- Damodhar SureshEdgewood$17K
- Saeb KhouryEdgewood$17K
- Paul HoulihanEdgewood$11K
- Abiodun IsholaEdgewood$10K
- Avichai EresLexington$616K
- Steve LinLexington$362K
- Daniel StewartLouisville$290K
- Robert SawyerLexington$249K
- Ganesh Keshav ThirunavukkarasuLexington$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.